CTSO News

Latest breaking news and updates for CTSO stock.

Track all markets on TradingView

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

LYMPHIR commercial availability planned for the fourth quarter of 2025 $12.5 million in gross financings raised during the quarter by Citius Pharmaceuticals, with an additional $9 million raised by...

What are the potential upside and downside scenarios for LYMPHIR's commercial performance? What is the company's strategy for market penetration and reimbursement for LYMPHIR upon launch? What is the expected impact on the stock price in the near term given the earnings release and the upcoming launch?
Earnings
16 days ago
Read more prnewswire

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using ...

How might the sentiment score of 30 affect market perception and short‑term sentiment‑driven trading strategies? Are there any red flags in the MD&A (e.g., increasing operating expenses, inventory buildup, or litigation) that could signal future challenges? What impact could the reported results have on the short‑term technical analysis patterns (e.g., support/resistance, volume spikes) for CTSO?
Earnings
21 days ago
Read more prnewswire